PHD BIOSCIENCES

Wins Two New SBIR Awards

PHD Biosciences hires new Research Scientist and wins two new SBIR awards.

Aug 2015

PHD BIOSCIENCES HIRES NEW RESEARCH SCIENTIST

PHD Biosciences has hired Dr. Grace Chen as a Research Scientist. Dr. Chen was a postdoctoral associate in the laboratory of Paul Frenette at the Albert Einstein College of Medicine, and will lead the new PHD sickle cell disease project.

Aug 2015

PHD BIOSCIENCES WINS PHASE I SBIR FROM NCATS

PHD Biosciences has been awarded a $225,000 Phase I SBIR from the National Center for Advancing Translational Science (NCATS) to support the translational development of its novel small molecule therapeutic for sickle cell disease (SCD).  The funding will be used to demonstrate the feasibility of the new PHD approach to treat acute sickle cell crisis, and adds tremendous value and credibility to the robust SCD program at PHD Biosciences.

Aug 2015

PHD BIOSCIENCES WINS PHASE II SBIR FROM THE NATIONAL CANCER INSTITUTE

PHD Biosciences has been awarded a $1.5 million Direct Phase II SBIR from the National Cancer Institute to support the translational development of its small molecule enzyme inhibitor for oncology.  The award will allow PHD to complete the IND-enabling studies and advance its lead drug candidate into human clinical trials.PHD Biosciences has been awarded a $1.5 million Direct Phase II SBIR from the National Cancer Institute to support the translational development of its small molecule enzyme inhibitor for oncology.  The award will allow PHD to complete the IND-enabling studies and advance its lead drug candidate into human clinical trials.

April 2015

PHD BIOSCIENCES WINS FIRST PRIZE AT ACS ENTREPRENEURIAL SHOWCASE

PHD Biosciences wins $10,000 prize for best pitch at the ACS Entrepreneural Showcase in San Diego for presenting the MTDIA technology.

Feb 2013

STEVE AND MICHAEL ISAACMAN CO-AUTHOR A NEW COLUMN FOR C&T MAGAZINE

Steve Isaacman, Ph.D. and Michael Isaacman, Ph.D. have been recruited to author a quarterly column for Cosmetics & Toiletries (C&T) magazine. The Technology Transfer column will highlight recent advances in academia that have potential applications in the dermatological space.

July 2013

PHD BIOSCIENCES COLLABORATES WITH NEW YORK UNIVERSITY

PHD Biosciences will collaborate with New York University to develop a novel heterobifunctional technology that has potential applications in bio-conjugation, and biomedical sciences.

Oct 2013

PHD BIOSCIENCES WINS PHASE II SBIR AWARD FROM THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE

PHD Biosciences has been awarded a $2.6 million Phase II SBIR to support the development of its novel strategy to treat sickle cell disease. The marks a milestone in the emergence of the PHD Biosciences sickle cell disease program.

Oct 2013

PHD BIOSCIENCES WINS AWARD FROM THE AVON FOUNDATION FOR WOMEN

PHD Biosciences has been awarded $100,000 from the Avon Foundation for Women to support the translational development of its lead small molecule therapeutic for triple negative breast cancer.

Oct 2013

PHD BIOSCIENCES WINS FIRST NEW YORK STATE CENTER FOR ADVANCED TECHNOLOGY AWARD

PHD Biosciences has been awarded $80,000 from the Stony Brook University Center for Advanced Biomedical and Bioengineering Technology to support the translational development of its lead small molecule therapeutic for triple negative breast cancer.

June 2014

PHD BIOSCIENCES WINS SECOND NEW YORK STATE CENTER FOR ADVANCED TECHNOLOGY AWARD

PHD Biosciences has been awarded a $50,000 award from the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology to support the development of a small molecule therapeutic for triple negative breast cancer.

Oct 2014

PHD BIOSCIENCES WINS PHASE I STTR AWARD FROM THE NATIONAL CANCER INSTITUTE

PHD Biosciences has been awarded a $225,000 Phase I STTR from the National Cancer Institute to support the translational development of small molecule anti-cancer therapeutics for triple negative breast cancer.

Oct 2014

PHD BIOSCIENCES WINS PHASE II SBIR AWARD FROM THE NATIONAL CANCER INSTITUTE

PHD Biosciences has been awarded a $1.5 million Phase II SBIR from the National Cancer Institute to support the translational development of its long-wear sunscreen technology for skin cancer prevention.

Nov 2014

PHD BIOSCIENCES WINS THIRD NEW YORK STATE CENTER FOR ADVANCED TECHNOLOGY AWARD

PHD Biosciences has been awarded $50,000 from the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology to support the “Testing of Oral therapeutic for Triple Negative Breast Cancer”.

FEB 2015

PHD BIOSCIENCES COLLABORATES WITH PHD SKIN CARE

PHD Biosciences will collaborate with PHD Skin Care on the development of topical formulations for skin cancer prevention. The collaboration will utilize the PHD Biosciences long-wear sunscreen technology in the PHD Skin Care Never Miss A Spot applicator to provide for the most efficient sunscreen products available.

INFO@PHDBIOSCIENCES | 646.801.3872 | 14 EAST 4TH STREET,   SUITE 811, NEW YORK, NY 10012      ©2016 PHDBIOSCIENCES